Skip to main content
SpringerLink
Log in

Leukotrienes and aspirin-intolerant asthma

  • Chapter
Novel Inhibitors of Leukotrienes

Part of the book series: Progress in Inflammation Research ((PIR))

  • 88 Accesses

Abstract

Most people tolerate aspirin well. Asthmatics, however, are an exception. In a sub-set of asthmatics, aspirin precipitates accute asthmatic attacks. This is a distinct clinical syndrome, called aspirin-induced asthma, or aspirin-intolerant asthma (AIA). It affects about 10% of adult patients with asthma, more often women than men, but is rare in asthmatic children [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Samter M, Beers RF (1968) Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Int Med 68: 975–983

    PubMed  CAS  Google Scholar 

  2. Stevenson DD (1984) Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 74: 617–622

    Article  PubMed  CAS  Google Scholar 

  3. Szczeklik A (1992) Aspirin-induced asthma. In: JR Vane, RM Botting (eds): Aspirin and other salicylates. Chapman and Hall Medical, London, 548–575

    Google Scholar 

  4. Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq JM, Durocher A, Tonnel AB (1992) Long-term prognosis for near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near-fatal attack of asthma. Am Rev Respir Dis 146: 76–81

    PubMed  CAS  Google Scholar 

  5. Bochenek G, Nizankowska E, Szczeklik A (1996) Atopy trait in hypersensitivity to non-steroidal anti-inflammatory drugs. Allergy 51: 16–23

    PubMed  CAS  Google Scholar 

  6. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1977) Clinical patterns of hyper-sensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis. J Allergy Clin Immunol 60: 276–284

    Article  PubMed  CAS  Google Scholar 

  7. Czerniawska-Mysik G, Szczeklik A (1981) Idiosyncrasy to pyrazolone drugs. Allergy 36: 381–384

    Article  PubMed  CAS  Google Scholar 

  8. Szczeklik A (1997) Mechanism of aspirin-induced asthma. Allergy 52: 613–619

    Article  PubMed  CAS  Google Scholar 

  9. Dahlen B, Boreus LO, Anderson P, Anderson R, Zetterstrom O (1994) Plasma acetyl-salicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects. Allergy 49: 43–49

    Article  PubMed  CAS  Google Scholar 

  10. Szczeklik A (1990) The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 588–593

    Google Scholar 

  11. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232–234

    CAS  Google Scholar 

  12. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1975) Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1: 67–69

    Article  PubMed  CAS  Google Scholar 

  13. Stevenson DD, Lewis RA (1987) Proposed mechanisms of aspirin sensitivity reactions. J Allergy Clin Immunol 80: 788–790

    Article  PubMed  CAS  Google Scholar 

  14. Lee TH (1992) Mechanism of aspirin sensitivity. Am Rev Respir Dis 145: 34–36

    Google Scholar 

  15. Sampson AP, Coburn AS, Sladek K, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen KF, Holgate ST (1997) Profound overexpression of leukotriene C4 synthase in aspirin-intolerant asthmatic bronchial biopsies. Int Arch Allergy Immunol 113: 355–357

    Article  PubMed  CAS  Google Scholar 

  16. Sousa AR, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M, Lee TH (1997) Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 52: 940–945

    Article  PubMed  CAS  Google Scholar 

  17. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen KF, Holgate ST et al (1998) Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101: 1–13

    Article  Google Scholar 

  18. Szczeklik A, Sladek K, Dworski R, Nizankowska E, Soja J, Sheller J, Oates J (1996) Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics. Am J Respir Crit Care Med 154: 1608–1614

    PubMed  CAS  Google Scholar 

  19. Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, White MV, Igarashi Y, Kaliner MA, Drazen JM et al (1994) Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 94: 1046–1056

    Article  PubMed  CAS  Google Scholar 

  20. Warren MS, Sloan SJ, Westcott JY, Hamilos D, Wenzel SE (1995) LTE4 increases in bronchoalveolar lavage fluid (BALF) of aspirin-intolerant asthmatics (AIA) after instillation of indomethacin. J Allergy Clin Immunol 95: 170,A119

    Google Scholar 

  21. O’Sullivan S, Dahlen B, Dahlen S-E, Kumlin M. (1996) Increased urinary excretion of the prostaglandin D2 metabolite 9α, 1113-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 98: 421–432

    Article  PubMed  Google Scholar 

  22. Szczeklik A, Dworski R, Mastalerz L, Prokop A, Sheller JR, Nizankowska E, Cmiel A, Oates JA (1998) Salmeterol prevents aspirin-precipitated attacks of asthma and interferes with eicosanoid metabolism. Am J Respir Crit Care Med 158: 1168–1172

    PubMed  CAS  Google Scholar 

  23. Szczeklik A (1988) Aspirin-induced asthma as a viral disease. Clin Allergy 18: 15–20

    Article  PubMed  CAS  Google Scholar 

  24. Smith CM, Hawksworth RJ, Thien FC, Christie PE, Lee TH (1992) Urinary leukotriene E4 in bronchial asthma. Eur Respir J 5: 693–699

    PubMed  CAS  Google Scholar 

  25. Kumlin M, Dahlen B, Bjorck T, Zetterstrom O, Granstrom E, Dahlen S-E (1992) Uri-nary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. Am Rev Respir Dis 146: 96–103

    PubMed  CAS  Google Scholar 

  26. Sladek K, Szczeklik A (1993) Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 6: 391–399

    PubMed  CAS  Google Scholar 

  27. Ortolani C, Mirone C, Fontana A, Folco GC, Miadonna A, Montalbetti N, Rinaldi M, Sala A, Tedeschi A, Valente D (1987) Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy 59: 106–112

    PubMed  CAS  Google Scholar 

  28. Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, White MV, Wojciechowska B, Brayton P, Kaulbach H, Rozniecki J, Kaliner MA (1993) Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 91: 580–598

    Google Scholar 

  29. Mewes T, Riechelmann H, Klimek L (1996) Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance. Allergy 51: 506–510

    PubMed  CAS  Google Scholar 

  30. In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, Collins T, Fisher AR, Keith TP, Serino K et al (1997) Naturally occuring mutation in the human 5-lipoxygenase gene promoter that modifies transcription factor binding and reporter gene transcription. J Clin Invest 99: 1130–1137

    Article  PubMed  CAS  Google Scholar 

  31. Penrose JF, Spector J, Baldasaro M, Xu K, Arm JP, Austen KF, Lam BK (1996) Molecular cloning for human LTC4 synthase: organization, nucleotide sequence and chromosomal localization to 5q35. J Biol Chem 271: 11356–11361

    Article  PubMed  CAS  Google Scholar 

  32. Sanak M, Simon H-U, Szczeklik A (1997) Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350: 1599–1600

    Article  PubMed  CAS  Google Scholar 

  33. Kowalski ML (1992) Management of aspirin-sensitive rhinosinusitis-asthma syndrome: What role for aspirin desensitization? Allergy Proc 13: 175–184

    Article  PubMed  CAS  Google Scholar 

  34. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA, Jolla L (1996) Aspirin desensitization/treatment of aspirin-sensitive rhinosinusitic-asthmatic patients: long term outcomes. J Allergy Clin Immunol 98: 751–758

    Article  PubMed  CAS  Google Scholar 

  35. Arm JP, O’Hickey SP, Spur B, Lee TH (1989) Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 140: 148–153

    Article  PubMed  CAS  Google Scholar 

  36. Joergens UR, Christiansen SC, Stevenson DD, Zuraw BL (1995) Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Immunol 96: 148–156

    Article  Google Scholar 

  37. Nasser S, Patel M, Bell GS, Lee TH (1995) The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. Am J Respir Crit Care Med 151: 1326–1330

    PubMed  CAS  Google Scholar 

  38. Christie PE, Smith CM, Lee TH (1991) The potent and selective sulfidopeptide leukotriene antagonist SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 144: 957–958

    Article  PubMed  CAS  Google Scholar 

  39. Yamamoto H, Nagata M, Kuramitsu K, Tabe K, Kiuchi H, Sakamoto Y, Yamamoto K, Dohi Y (1994) Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ON)-VC 1078. Am J Respir Crit Care Med 150: 254–257

    PubMed  CAS  Google Scholar 

  40. Israel E, Fisher AR, Rosenberg MA, Lilly CM, Gallery JC, Hapiro J, Cohn J, Rubin P, Drazen JM (1993) The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Resp Dis 148: 1447–1451

    Article  PubMed  CAS  Google Scholar 

  41. Dahlen B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodho TI et al (1998) Benefits from adding the 5lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 157: 1187–1194

    PubMed  CAS  Google Scholar 

  42. Kuna P, Malmstrom K, Dahlen S-E, Nizankowska E, Kowalski M, Stevenson D, Bousquet J, Dahlen B, Picado C, Lumry W et al (1997) Montelukast (MK-0476) a CysLT1 receptor antagonist improves asthma control in aspirin-intolerant asthmatic patients. Am J Respir Crit Care Med 155: A975

    Google Scholar 

  43. Mastalerz L, Milewski M, Duplaga M, Nizankowska E, Szczeklik A (1997) Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 52: 895–900

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Jagellonian University School of Medicine, Skawinska Str. 8, Kraków, 31-066, Poland

    Andrzej Szczeklik & Marek Sanak

Authors
  1. Andrzej Szczeklik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marek Sanak
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Cardiopulmonary Pharmacology Institute of Pharmacological Sciences, University of Milan, Via Balzaretti 9, Milan, 20133, Italy

    Giancarlo Folco

  2. Department of Medical Biochemistry and Biophysics Division of Physiological Chemistry II, Karolinska Institute, Stockholm, 10401, Sweden

    Bengt Samuelsson

  3. National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO, 80206, USA

    Robert C. Murphy

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this chapter

Cite this chapter

Szczeklik, A., Sanak, M. (1999). Leukotrienes and aspirin-intolerant asthma. In: Folco, G., Samuelsson, B., Murphy, R.C. (eds) Novel Inhibitors of Leukotrienes. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8703-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8703-8_11

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9736-5

  • Online ISBN: 978-3-0348-8703-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation